NovoCure (NVCR) Tax Rate (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,289.00 |
| Dec 31, 2025 | 6,432.00 |
| Sep 30, 2025 | -939.00 |
| Jun 30, 2025 | -147.00 |
| Mar 31, 2025 | 613.00 |
| Dec 31, 2024 | 2,222.00 |
| Sep 30, 2024 | 521.00 |
| Jun 30, 2024 | -2,434.00 |
| Mar 31, 2024 | -32.00 |
| Dec 31, 2023 | -1,956.00 |
| Sep 30, 2023 | 390.00 |
| Jun 30, 2023 | -264.00 |
| Mar 31, 2023 | 1,070.00 |
| Dec 31, 2022 | -108.00 |
| Sep 30, 2022 | -1,070.00 |
| Jun 30, 2022 | 8,198.00 |
| Mar 31, 2022 | -8,131.00 |
| Dec 31, 2021 | 2,114.00 |
| Sep 30, 2021 | -1,398.00 |
| Jun 30, 2021 | 4,036.00 |
| Mar 31, 2021 | -9,527.00 |
| Dec 31, 2020 | 2,839.00 |
| Sep 30, 2020 | -4,325.00 |
| Jun 30, 2020 | -10,884.00 |
| Mar 31, 2020 | -19,960.00 |
| Dec 31, 2019 | 41,605.00 |
| Sep 30, 2019 | 280,503.00 |
| Jun 30, 2019 | -281,036.00 |
| Mar 31, 2019 | 128.00 |
| Dec 31, 2018 | 859.00 |
| Sep 30, 2018 | 296.00 |
| Jun 30, 2018 | -3,774.00 |
| Mar 31, 2018 | 4,063.00 |
| Dec 31, 2017 | -1,646.00 |
| Sep 30, 2017 | -2,285.00 |
| Jun 30, 2017 | -547.00 |
| Mar 31, 2017 | -1,643.00 |
| Dec 31, 2016 | 1,278.00 |
| Sep 30, 2016 | -296.00 |
| Jun 30, 2016 | 162.00 |
| Mar 31, 2016 | -448.00 |
| Dec 31, 2015 | -70.00 |
| Sep 30, 2015 | 64.00 |
| Jun 30, 2015 | -127.00 |
| Mar 31, 2015 | -285.00 |
| Dec 31, 2014 | 160.00 |